Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Masuda

Showing results (741-750 of 839) with videos related to

Pageof 84
Sort By:
Anticancer Research|January 8, 2000
Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositolH Nishino, M Murakoshi, M Masuda, et al.
American Journal of Respiratory and Critical Care Medicine|July 21, 2001
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertensionH Kimura, O Okada, N Tanabe, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 2, 2001
[Clinical outcome and analysis of radical prostatectomy in clinical stage B and C prostate cancer]Y Miyoshi, H Uemura, K Mikata, et al.
British Journal of Haematology|September 1, 2001
Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangementsT Shimamoto, T Iguchi, K Ando, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|November 21, 2007
[Surgical treatment for pulmonary aspergillosis with hyper immunoglobulin-E syndrome; report of a case]Hiromasa Arai, Y Rino, K Fujii, et al.
Infection and Immunity|November 24, 1999
Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a gln residue in the conserved G-3 domain of the rho family and preferentially inhibits the GTPase activity of RhoA and rac1M Sugai, K Hatazaki, A Mogami, et al.
Journal of Molecular and Cellular Cardiology|February 1, 1997
Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiencyK Yoshimine, M Horiuchi, S Suzuki, et al.
Oncology Reports|February 19, 1999
A phase I study of cisplatin i.p. and carboplatin i.v. with G-CSF in patients with ovarian cancerS Adachi, K Ito, Y Itani, et al.
The Annals of Thoracic Surgery|January 1, 1997
Aortic arch operation using selective cerebral perfusion for nondissecting thoracic aneurysmJ Hayashi, S Eguchi, K Yasuda, et al.
Annals of Surgical Oncology|March 11, 2015
A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic TreatmentH Fujikawa, K Sakamaki, T Kawabe, et al.
Pageof 84

Showing results (741-750 of 839) with videos related to

Sort By:
Pageof 84
Anticancer Research|January 8, 2000
Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositolH Nishino, M Murakoshi, M Masuda, et al.
American Journal of Respiratory and Critical Care Medicine|July 21, 2001
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertensionH Kimura, O Okada, N Tanabe, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 2, 2001
[Clinical outcome and analysis of radical prostatectomy in clinical stage B and C prostate cancer]Y Miyoshi, H Uemura, K Mikata, et al.
British Journal of Haematology|September 1, 2001
Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangementsT Shimamoto, T Iguchi, K Ando, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|November 21, 2007
[Surgical treatment for pulmonary aspergillosis with hyper immunoglobulin-E syndrome; report of a case]Hiromasa Arai, Y Rino, K Fujii, et al.
Infection and Immunity|November 24, 1999
Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a gln residue in the conserved G-3 domain of the rho family and preferentially inhibits the GTPase activity of RhoA and rac1M Sugai, K Hatazaki, A Mogami, et al.
Journal of Molecular and Cellular Cardiology|February 1, 1997
Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiencyK Yoshimine, M Horiuchi, S Suzuki, et al.
Oncology Reports|February 19, 1999
A phase I study of cisplatin i.p. and carboplatin i.v. with G-CSF in patients with ovarian cancerS Adachi, K Ito, Y Itani, et al.
The Annals of Thoracic Surgery|January 1, 1997
Aortic arch operation using selective cerebral perfusion for nondissecting thoracic aneurysmJ Hayashi, S Eguchi, K Yasuda, et al.
Annals of Surgical Oncology|March 11, 2015
A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic TreatmentH Fujikawa, K Sakamaki, T Kawabe, et al.
Pageof 84